Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021)
Zimmer Biomet Holdings' (ZBH) quarterly Liabilities from Discontinued Operations came in at 168400000.0 in Q4 2021.
Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021) Analysis & Trends
Zimmer Biomet Holdings' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 168400000.0 for Q4 2021.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 168400000.0 in Q4 2021; TTM through Dec 2021 was 168400000.0, a N/A change from a year earlier, with the FY2021 full-year figure at 168400000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 168400000.0 in Q4 2021 per ZBH's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 168400000.0 in Q4 2021 and bottomed at 168400000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 168.40 Mn |
| Dec 31, 2021 | 168.40 Mn |